{
  "stock_id": "6621",
  "stock_name": "華宇藥",
  "industry_category": "生技醫療業",
  "type": "emerging",
  "backtest_period": "2024-02-15 ~ 2026-02-25",
  "initial_capital": 1000000,
  "buy_and_hold_return_pct": 7.4,
  "daily_volatility_pct": 3.23,
  "viable_strategies": [
    {
      "rank": 1,
      "name": "ATR通道回歸",
      "category": "逆勢",
      "description": "價格低於20日均線-1.5×ATR買入，回到均線賣出",
      "stop_loss": "固定停損-8%",
      "total_return_pct": 82.91,
      "final_capital": 1829087,
      "trades": 11,
      "win_rate_pct": 100.0,
      "avg_holding_days": 14.2,
      "max_drawdown_pct": 8.63,
      "sharpe_ratio": 1.85,
      "stop_loss_count": 0
    }
  ],
  "backtest_engine": "backtest.py",
  "engine_version": "v2"
}